197 related articles for article (PubMed ID: 1478157)
1. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
Katoh K
Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
[TBL] [Abstract][Full Text] [Related]
4. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
[TBL] [Abstract][Full Text] [Related]
5. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests.
Armstrong D; Abdella N; Salman A; Miller N; Rahman EA; Bojancyzk M
J Diabetes Complications; 1992; 6(2):116-22. PubMed ID: 1611135
[TBL] [Abstract][Full Text] [Related]
6. Vascular complications of patients in Kuwait with type 2 diabetes mellitus (NIDDM) and elevated serum lipid peroxides.
Lanham RJ; Armstrong D; Abdella N
Adv Exp Med Biol; 1994; 366():433-5. PubMed ID: 7771283
[No Abstract] [Full Text] [Related]
7. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between free radicals and diabetic microangiopathy].
Li H; Tang ZH; Xia TQ
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):402-4, 455. PubMed ID: 1752151
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
10. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
11. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients.
Jain SK; Krueger KS; McVie R; Jaramillo JJ; Palmer M; Smith T
Diabetes Care; 1998 Sep; 21(9):1511-6. PubMed ID: 9727900
[TBL] [Abstract][Full Text] [Related]
12. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
13. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
14. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
[TBL] [Abstract][Full Text] [Related]
15. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella F; Healy D; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463
[TBL] [Abstract][Full Text] [Related]
16. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
Yamanaka S; Miura K; Yukimura T; Yamamoto K
Prostaglandins; 1993 Mar; 45(3):221-8. PubMed ID: 8484010
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin E administration on platelet function in diabetes mellitus.
Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
[TBL] [Abstract][Full Text] [Related]
18. Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.
Florkowski CM; Richardson MR; Le Guen C; Jennings PE; O'Donnell MJ; Jones AF; Lunec J; Barnett AH
Diabetes Res; 1988 Oct; 9(2):87-90. PubMed ID: 3149923
[TBL] [Abstract][Full Text] [Related]
19. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine.
Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW
Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
